Insights with Goldman Sachs Part 6: Generating investor interest
Good news! We’re currently seeing one of the largest pools of capital invested in biopharma. Generalist capital is coming back to the market. There’s a shift toward later-stage assets, but investors will be looking for proof points across different stages of development. Get more insights from Lyla Bibi, Managing Director, Head of Americas Healthcare Equity Capital Markets at Goldman Sachs.
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action.
Related Insights
Video
Insights with Goldman Sachs Part 1: Future predictions
Jan 26, 2024
Video
Insights with Goldman Sachs Part 2: How pharma is using M&A for growth and innovation
Jan 26, 2024
Video
Insights with Goldman Sachs Part 3: Regulatory dynamics and research trends
Jan 26, 2024
Video
Insights with Goldman Sachs Part 4: The impact of the Inflation Reduction Act
Jan 26, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024